Learn more about subcutaneous treatments for cancer, how medicines are given under the skin, why this approach may be used, what patients can expect during treatment, and factors that can influence treatment choices. This informational guide also explains common considerations, possible reactions, monitoring, and questions patients may discuss with their healthcare team when exploring subcutaneous cancer treatment options.
Subcutaneous treatments for cancer involve delivering certain medicines into the tissue beneath the skin rather than directly into a vein. This approach may be appropriate for some cancer medicines and treatment plans, depending on the medication, cancer type, patient needs, and clinical guidance. Understanding how subcutaneous treatment works can help patients and caregivers prepare for appointments and know what to expect. This guide explains the basic process, reasons healthcare professionals may consider this method, common treatment considerations, possible reactions, and questions to discuss with a healthcare team. It provides general educational information and does not replace individualized medical advice.
Cancer treatment can involve several methods of delivering medicines, and subcutaneous administration is one approach used for certain therapies. In this method, medicine is injected into the fatty tissue beneath the skin. The specific treatment, dosage, schedule, and administration method depend on the medicine and the patient's treatment plan.
Subcutaneous treatment delivers medication into the layer of tissue located beneath the skin. From there, the medicine is gradually absorbed into the body. Healthcare professionals determine whether this method is suitable based on the particular medicine and the patient's circumstances.
The injection is generally given in an area recommended by the healthcare team. Treatment may be administered by a healthcare professional, while some medicines may allow appropriate patients or caregivers to receive training for administration at home.
Common considerations include:
Some medicines can be administered through more than one route. When clinically appropriate, subcutaneous administration may provide an alternative to intravenous delivery. The choice depends on the medicine's formulation, effectiveness, safety information, and individual treatment requirements.
Subcutaneous treatment may involve a relatively small injection rather than placement of an intravenous line. However, whether it is appropriate varies considerably between medicines and patients.
Factors that may influence the choice include:
Before receiving a subcutaneous cancer medicine, healthcare professionals may review the treatment plan and explain how the medicine will be administered. The injection site is prepared, and the medicine is delivered beneath the skin using an appropriate needle or injection device.
Some people may experience temporary discomfort at the injection site. The healthcare team may provide instructions about what to monitor after treatment and when to report concerns.
Patients may want to ask about:
Like other forms of cancer treatment, medicines administered subcutaneously can have side effects. These vary according to the medication, dose, cancer type, and individual response. Injection site reactions can sometimes occur, while other effects may be related to the medicine itself.
Patients should follow the instructions provided by their healthcare team and report unusual or concerning symptoms. Regular monitoring may be part of the treatment plan to assess how the medicine is working and identify potential problems.
Important points to consider include: